Total Debt Summary of BioSyent Inc.

BioSyent Inc.'s latest annual total debt in 2023 was 1.22 Million CAD , down -12.48% from previous year.
BioSyent Inc.'s latest quarterly total debt in 2024 Q2 was 1.13 Million CAD , down -3.88% from previous quarter.
BioSyent Inc. reported annual total debt of 1.39 Million CAD in 2022, down -10.39% from previous year.
BioSyent Inc. reported annual total debt of 1.55 Million CAD in 2021, down -8.89% from previous year.
BioSyent Inc. reported quarterly total debt of 1.13 Million CAD for 2024 Q2, down -3.88% from previous quarter.
BioSyent Inc. reported quarterly total debt of 1.26 Million CAD for 2023 Q3, down -3.33% from previous quarter.

Annual Total Debt Chart of BioSyent Inc. (2023 - 1997)

Historical Annual Total Debt of BioSyent Inc. (2023 - 1997)

Year	Total Debt	Total Debt Growth
2023	1.22 Million CAD	-12.48%
2022	1.39 Million CAD	-10.39%
2021	1.55 Million CAD	-8.89%
2020	1.7 Million CAD	-7.78%
2019	1.85 Million CAD	0.0%
2018	- CAD	0.0%
2017	- CAD	0.0%
2016	- CAD	0.0%
2015	- CAD	0.0%
2014	- CAD	0.0%
2013	- CAD	0.0%
2012	- CAD	0.0%
2011	- CAD	0.0%
2010	- CAD	0.0%
2009	- CAD	0.0%
2008	- CAD	0.0%
2007	- CAD	0.0%
2006	- CAD	0.0%
2005	- CAD	0.0%
2004	- CAD	0.0%
2003	- CAD	0.0%
2002	- CAD	-100.0%
2001	500 Thousand CAD	0.0%
2000	- CAD	0.0%
1999	- CAD	-100.0%
1998	200 Thousand CAD	0.0%
1997	200 Thousand CAD	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	1.17 Million CAD	-3.69%
2024 Q2	1.13 Million CAD	-3.88%
2023 Q3	1.26 Million CAD	-3.33%
2023 Q4	1.22 Million CAD	-3.5%
2023 Q1	1.35 Million CAD	-3.08%
2023 FY	1.22 Million CAD	-12.48%
2023 Q2	1.3 Million CAD	-3.2%
2022 Q4	1.39 Million CAD	-2.92%
2022 Q2	1.47 Million CAD	-2.62%
2022 Q3	1.43 Million CAD	-2.74%
2022 FY	1.39 Million CAD	-10.39%
2022 Q1	1.51 Million CAD	-2.54%
2021 Q1	1.67 Million CAD	-2.2%
2021 FY	1.55 Million CAD	-8.89%
2021 Q3	1.59 Million CAD	-2.33%
2021 Q2	1.63 Million CAD	-2.26%
2021 Q4	1.55 Million CAD	-2.42%
2020 Q1	1.81 Million CAD	-1.93%
2020 FY	1.7 Million CAD	-7.78%
2020 Q3	1.74 Million CAD	-2.03%
2020 Q2	1.78 Million CAD	-1.97%
2020 Q4	1.7 Million CAD	-2.1%
2019 Q3	1.87 Million CAD	0.0%
2019 Q4	1.85 Million CAD	-1.22%
2019 Q2	- CAD	0.0%
2019 Q1	- CAD	0.0%
2019 FY	1.85 Million CAD	0.0%
2018 Q3	- CAD	0.0%
2018 Q4	- CAD	0.0%
2018 FY	- CAD	0.0%
2018 Q1	- CAD	0.0%
2018 Q2	- CAD	0.0%
2017 FY	- CAD	0.0%
2017 Q2	- CAD	0.0%
2017 Q3	- CAD	0.0%
2017 Q4	- CAD	0.0%
2017 Q1	- CAD	0.0%
2016 Q4	- CAD	0.0%
2016 FY	- CAD	0.0%
2016 Q3	- CAD	0.0%
2016 Q1	- CAD	0.0%
2016 Q2	- CAD	0.0%
2015 Q4	- CAD	0.0%
2015 Q1	- CAD	0.0%
2015 Q2	- CAD	0.0%
2015 Q3	- CAD	0.0%
2015 FY	- CAD	0.0%
2014 Q4	- CAD	0.0%
2014 Q2	- CAD	0.0%
2014 Q3	- CAD	0.0%
2014 FY	- CAD	0.0%
2014 Q1	- CAD	0.0%
2013 FY	- CAD	0.0%
2013 Q3	- CAD	0.0%
2013 Q4	- CAD	0.0%
2013 Q1	- CAD	0.0%
2013 Q2	- CAD	0.0%
2012 Q4	- CAD	0.0%
2012 Q3	- CAD	0.0%
2012 Q2	- CAD	0.0%
2012 FY	- CAD	0.0%
2012 Q1	- CAD	0.0%
2011 FY	- CAD	0.0%
2011 Q4	- CAD	0.0%
2011 Q3	- CAD	0.0%
2011 Q2	- CAD	0.0%
2011 Q1	- CAD	0.0%
2010 Q4	- CAD	0.0%
2010 FY	- CAD	0.0%
2010 Q1	- CAD	0.0%
2010 Q2	- CAD	0.0%
2010 Q3	- CAD	0.0%
2009 Q4	- CAD	0.0%
2009 Q2	- CAD	0.0%
2009 Q3	- CAD	0.0%
2009 FY	- CAD	0.0%
2009 Q1	- CAD	0.0%
2008 Q2	- CAD	0.0%
2008 Q3	- CAD	0.0%
2008 Q4	- CAD	0.0%
2008 FY	- CAD	0.0%
2008 Q1	- CAD	0.0%
2007 Q2	- CAD	0.0%
2007 Q1	- CAD	0.0%
2007 FY	- CAD	0.0%
2007 Q4	- CAD	0.0%
2007 Q3	- CAD	0.0%
2006 FY	- CAD	0.0%
2006 Q1	- CAD	0.0%
2006 Q3	- CAD	0.0%
2006 Q2	- CAD	0.0%
2006 Q4	- CAD	0.0%
2005 FY	- CAD	0.0%
2005 Q2	- CAD	0.0%
2005 Q1	- CAD	0.0%
2005 Q3	- CAD	0.0%
2005 Q4	- CAD	0.0%
2004 Q4	- CAD	0.0%
2004 Q3	- CAD	0.0%
2004 Q2	- CAD	0.0%
2004 Q1	- CAD	0.0%
2004 FY	- CAD	0.0%
2003 Q4	- CAD	0.0%
2003 FY	- CAD	0.0%
2003 Q3	- CAD	0.0%
2003 Q2	- CAD	0.0%
2003 Q1	- CAD	0.0%
2002 FY	- CAD	-100.0%
2002 Q1	- CAD	-100.0%
2002 Q2	- CAD	0.0%
2002 Q3	- CAD	0.0%
2002 Q4	- CAD	0.0%
2001 Q3	79.94 Thousand CAD	0.0%
2001 Q4	500 Thousand CAD	525.45%
2001 FY	500 Thousand CAD	0.0%
2001 Q1	- CAD	0.0%
2001 Q2	- CAD	0.0%
2000 Q4	- CAD	-100.0%
2000 FY	- CAD	0.0%
2000 Q2	500 Thousand CAD	0.0%
2000 Q3	20 Thousand CAD	-96.0%
2000 Q1	- CAD	0.0%
1999 FY	- CAD	-100.0%
1999 Q1	200 Thousand CAD	0.0%
1999 Q3	500 Thousand CAD	0.0%
1999 Q4	- CAD	-100.0%
1999 Q2	500 Thousand CAD	150.0%
1998 Q2	- CAD	-100.0%
1998 Q3	- CAD	0.0%
1998 Q1	200 Thousand CAD	0.0%
1998 Q4	200 Thousand CAD	0.0%
1998 FY	200 Thousand CAD	0.0%
1997 FY	200 Thousand CAD	0.0%
1997 Q3	- CAD	0.0%
1997 Q4	200 Thousand CAD	0.0%

Peer Total Debt Comparison of BioSyent Inc.

Name	Total Debt	Total Debt Difference
Aequus Pharmaceuticals Inc.	5.06 Million CAD	75.887%
CanadaBis Capital Inc.	7.3 Million CAD	83.295%
Decibel Cannabis Company Inc.	40.96 Million CAD	97.019%
Delivra Health Brands Inc.	2.02 Million CAD	39.761%
Entourage Health Corp.	161.58 Million CAD	99.244%
Lifeist Wellness Inc.	1.26 Million CAD	3.552%
Cannara Biotech Inc.	45.78 Million CAD	97.333%
Medicure Inc.	544 Thousand CAD	-124.457%
PharmaCielo Ltd.	18.3 Million CAD	93.331%
Rubicon Organics Inc.	10.25 Million CAD	88.098%
Voyageur Pharmaceuticals Ltd.	40 Thousand CAD	-2952.613%

Global Stocks Search

BioSyent Inc. (RX.V)

Total Debt Summary of BioSyent Inc.

Annual Total Debt Chart of BioSyent Inc. (2023 - 1997)

Historical Annual Total Debt of BioSyent Inc. (2023 - 1997)

Peer Total Debt Comparison of BioSyent Inc.